参考文献/References:
[1] Mohammadi S,Kayedpoor P,Karimzadeh-Bardei L,et al.The effect of curcumin on TNF-α, IL-6 and CRP expression in a model of polycystic ovary syndrome as an inflammation state[J].J Reprod Infertil,2017,18(4):352-360.
[2] Guimarães PM,Scavuzzi BM,Stadtlober NP,et al.Cytokines in systemic lupus erythematosus:far beyond Th1/Th2 dualism lupus:cytokine profiles[J].Immunol Cell Biol,2017,95(9):824-831.DOI:10.1038/icb.2017.53.
[3] Hao Y,Li Y,Li H,et al.Increased plasma sCXCL16 levels may have a relationship with Th1/Th2 imbalance in primary immune thrombocytopenia[J].Cytokine,2017,99:124-131.DOI:10.1016/j.cyto.2017.08.024.
[4] Bing X,Xuelei L,Wanwei D,et al.EGCG maintains Th1/Th2 balance and mitigates ulcerative colitis induced by dextran sulfate sodium through TLR4/MyD88/NF-κB signaling pathway in rats[J].Can J Gastroenterol Hepatol,2017,2017:3057268.DOI:10.1155/2017/3057268.
[5] Semeniuk LM,Likhachov VK,Yuzvenko TY,et al.Risk markers of reproductive loss in women with hyperandrogenism[J].Wiad Lek,2018,71(8):1550-1553.
[6] Graff SK,Mario FM,Magalhães JA,et al.Saturated fat intake is related to heart rate variability in women with polycystic ovary syndrome[J].Ann Nutr Metab,2017,71(3-4):224-233.DOI:10.1159/000484325.
[7] Pasquali R. Metabolic syndrome in polycystic ovary syndrome[J].Front Horm Res,2018,49:114-130.DOI:10.1159/000485995.
[8] Gong P,Shi B,Wang J,et al.Association between Th1/Th2 immune imbalance and obesity in women with or without polycystic ovary syndrome[J].Gynecol Endocrinol,2018,34(8):709-714.DOI:10.1080/09513590.2018.1428301.
[9] Zhong J,Rao X,Braunstein Z,et al.T-cell costimulation protects obesity-induced adipose inflammation and insulin resistance[J].Diabetes,2014,63(4):1289-1302.DOI:10.2337/db13-1094.
[10] Castañeda S,Remuzgo-Martínez S,López-Mejías R,et al.Rapid beneficial effect of the IL-6 receptor blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis[J].Clin Exp Rheumatol,2019,37(3):465-473.
[11] Huang X,Wang Q,Liu T,et al.Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China[J].Endocrine,2019,65(1):81-85.DOI:10.1007/s12020-019-01912-1.
[12] Son M,Wu J.Egg white hydrolysate and peptide reverse insulin resistance associated with tumor necrosis factor-α(TNF-α)stimulated mitogen-activated protein kinase(MAPK)pathway in skeletal muscle cells[J].Eur J Nutr,2019,58(5):1961-1969.DOI:10.1007/s00394-018-1753-7.
[13] Fuseini H,Yung JA,Cephus JY,et al.Testosterone decreases house dust mite-induced type 2 and IL-17A-mediated airway inflammation[J].J Immunol,2018,201(7):1843-1854.DOI:10.4049/jimmunol.1800293.
[14] Moulana M.Immunophenotypic profile of leukocytes in hyperandrogenemic female rat an animal model of polycystic ovary syndrome[J].Life Sci,2019,220:44-49. DOI:10.1016/j.lfs.2019.01.048.
[15] Roved J,Westerdahl H,Hasselquist D.Sex differences in immune responses: hormonal effects, antagonistic selection, and evolutionary consequences[J].Horm Behav,2017,88:95-105.DOI:10.1016/j.yhbeh.2016.11.017.
[16] Kalhori Z,Soleimani Mehranjani M,Azadbakht M,et al.Ovary stereological features and serum biochemical factors following induction of polycystic ovary syndrome with testosterone enanthate in mice: an experimental study[J].Int J Reprod Biomed(Yazd),2018,16(4):267-274.
[17] Su C,Chen M,Huang H,et al.Testosterone enhances lipopolysaccharide-induced interleukin-6 and macrophage chemotactic protein-1 expression by activating the extracellular signal-regulated kinase 1/2/nuclear factor-κB signalling pathways in 3T3-L1 adipocytes[J].Mol Med Rep,2015,12(1):696-704.DOI:10.3892/mmr.2015.3401.
[18] Zhou Y,Lv L,Liu Q,et al.Total flavonoids extracted from Nervilia Fordii function in polycystic ovary syndrome through IL-6 mediated JAK2/STAT3 signaling pathway[J].Biosci Rep,2019,39(1):pii:BSR20181380.DOI:10.1042/BSR20181380.
[19] Deng Y,Zhang Y,Li S,et al.Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome[J].Sci Rep,2017,7(1):14156.DOI:10.1038/s41598-017-14534-2.
[20] Liang PY,Yin B,Cai J,et al.Increased circulating Th1/Th2 ratios but not other lymphocyte subsets during controlled ovarian stimulation are linked to subsequent implantation failure after transfer of in vitro fertilized embryos[J].Am J Reprod Immunol,2015,73(1):12-21.DOI:10.1111/aji.12320.
[21] Qin L,Xu W,Li X,et al.Differential expression profile of immunological cytokines in local ovary in patients with polycystic ovarian syndrome: analysis by flow cytometry[J].Eur J Obstet Gynecol Reprod Biol,2016,197:136-141. DOI:10.1016/j.ejogrb.2015.12.003.
[22] Nasri F,Doroudchi M,Namavar Jahromi B,et al.T helper cells profile and CD4+CD25+Foxp3+regulatory T cells in polycystic ovary syndrome[J].Iran J Immunol,2018,15(3):175-185.DOI:10.22034/IJI.2018.39387.
[23] Romualdi D,Versace V,Tagliaferri V,et al.The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study[J].J Endocrinol Invest,2019,42(9):1089-1097.DOI:10.1007/s40618-019-01029-2.
[24] Mejia RB,Summers KM,Kresowik JD,et al.A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome[J].Fertil Steril,2019,111(3):571-578.e1.DOI:10.1016/j.fertnstert.2018.11.030.
[25] Zhang J,Si Q,Li J.Therapeutic effects of metformin and clomiphene in combination with lifestyle intervention on infertility in women with obese polycystic ovary syndrome[J].Pak J Med Sci,2017,33(1):8-12.DOI:10.12669/pjms.331.11764.
[26] Sylus AM,Nandeesha H,Sridhar MG,et al.Clomiphene citrate increases nitric oxide, interleukin-10 and reduces matrix metalloproteinase-9 in women with polycystic ovary syndrome[J].Eur J Obstet Gynecol Reprod Biol,2018,228:27-31.DOI:10.1016/j.ejogrb.2018.06.007.
[27] Furat Rencber S,Kurnaz Ozbek S,Eraldemr C,et al.Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS:an experimental study[J].J Ovarian Res,2018,11(1):55.DOI:10.1186/s13048-018-0427-7.
[28] Miethe S,Guarino M,Alhamdan F,et al.Effects of obesity on asthma: immunometabolic links[J].Pol Arch Intern Med,2018,128(7-8):469-477.DOI:10.20452/pamw.4304.
[29] Ikemoto Y,Kuroda K,Nakagawa K,et al.Vitamin D regulates maternal T-helper cytokine production in infertile women[J].Nutrients,2018,10(7):pii:E902.DOI:10.3390/nu10070902.
相似文献/References:
[1]曹琳,杨昱,刘超.减重手术对多囊卵巢综合征的治疗作用[J].国际内分泌代谢杂志,2014,(06):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
Cao Lin,Yang Yu,Liu Chao..Therapeutic effects of bariatric surgery on polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2014,(01):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
[2]杨健姝,华飞,唐暎,等.二甲双胍在多囊卵巢综合征患者妊娠期的应用[J].国际内分泌代谢杂志,2014,(03):176.[doi:10.3760/cma.j.issn.1673-4157.2014.03.009]
Yang Jianshu,Hua Fei,Tang Ying,et al.The application of metformin in the pregnant patients with polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2014,(01):176.[doi:10.3760/cma.j.issn.1673-4157.2014.03.009]
[3]乔冠华,李强.胰高血糖素样肽-1受体激动剂治疗多囊卵巢综合征的研究进展[J].国际内分泌代谢杂志,2017,37(03):181.[doi:10.3760/cma.j.issn.1673-4157.2017.03.010]
Qiao Guanhua,Li Qiang..Glucagon like peptide-1 receptor agonist in the treatment of polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2017,37(01):181.[doi:10.3760/cma.j.issn.1673-4157.2017.03.010]
[4]司马盼盼 孙良阁.多囊卵巢综合征与自身免疫性甲状腺疾病的相关性[J].国际内分泌代谢杂志,2018,38(03):163.[doi:10.3760/cma.j.issn.1673-4157.2018.03.005]
Sima Panpan,Sun Liangge..Correlation between polycystic ovary syndrome and autoimmune thyroid disease[J].International Journal of Endocrinology and Metabolism,2018,38(01):163.[doi:10.3760/cma.j.issn.1673-4157.2018.03.005]
[5]廖鑫 张开羽 高琳 张晗 张琳 邓凡曲 黄琦 李思成 张凌.多囊卵巢综合征患者血清PTX3、vaspin
水平的观察研究[J].国际内分泌代谢杂志,2018,38(04):228.[doi:10.3760/cma.j.issn.1673-4157.2018.04.003]
Liao Xin*,Zhang Kaiyu,Gao Lin,et al.Study of serum PTX3 and vaspin levels in patients with polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2018,38(01):228.[doi:10.3760/cma.j.issn.1673-4157.2018.04.003]
[6]梁杏燕,赵捷,马红霞.自身免疫性甲状腺疾病对多囊卵巢综合征不良妊娠结局的影响[J].国际内分泌代谢杂志,2022,42(06):481.[doi:10.3760/cma.j.cn121383-20211016-10036]
Liang Xingyan,Zhao Jie,Ma Hongxia..Influence of autoimmune thyroid disease on adverse pregnant outcome in polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2022,42(01):481.[doi:10.3760/cma.j.cn121383-20211016-10036]
[7]车悦,陶弢.饮食干预对多囊卵巢综合征患者生殖功能影响的研究进展[J].国际内分泌代谢杂志,2023,43(01):62.[doi:10.3760/cma.j.cn121383-20211002-10001]
Che Yue,Tao Tao..Research progress of dietary intervention impact on reproduction in polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2023,43(01):62.[doi:10.3760/cma.j.cn121383-20211002-10001]
[8]蒋艺婕,杜科,华飞.铁代谢异常及铁死亡与多囊卵巢综合征关系的研究进展[J].国际内分泌代谢杂志,2023,43(02):124.[doi:10.3760/cma.j.cn121383-20220122-01046]
Jiang Yijie,Du Ke,Hua Fei..Relationship between abnormal iron metabolism, ferroptosis and polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2023,43(01):124.[doi:10.3760/cma.j.cn121383-20220122-01046]
[9]肖月茗,陶弢.慢性低度炎症对多囊卵巢综合征生殖功能异常影响的研究进展[J].国际内分泌代谢杂志,2023,43(06):481.[doi:10.3760/cma.j.cn121383-20230308-03023]
Xiao Yueming,Tao Tao..Research progress on the effects of chronic low-grade inflammation on reproductive dysfunction in polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2023,43(01):481.[doi:10.3760/cma.j.cn121383-20230308-03023]